ArticleiScience2022

Targeting histone methylation to reprogram the transcriptional state that drives survival of drug-tolerant myeloid leukemia persisters.

Noortje van Gils et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.